BCLI - BrainStorm Cell Therapeutics promotes Bob Dagher to Chief Medical Officer
2024-04-17 03:25:55 ET
More on BrainStorm Cell Therapeutics
- BrainStorm gains as FDA OKs Phase 3 trial design for ALS therapy
- BrainStorm submits SPA request to FDA for Phase 3 study design
- Seeking Alpha’s Quant Rating on BrainStorm Cell Therapeutics
- Historical earnings data for BrainStorm Cell Therapeutics
- Financial information for BrainStorm Cell Therapeutics